Improving Blood Pressure Control Through the myBPmyLife mHealth Application

Last updated: February 16, 2024
Sponsor: University of Michigan
Overall Status: Completed

Phase

N/A

Condition

Stress

Circulation Disorders

Vascular Diseases

Treatment

Control Group

Dietary and physical activity JITAI delivered through the myBPmyLife app

Clinical Study ID

NCT05154929
HUM00205845
  • Ages > 18
  • All Genders

Study Summary

This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which together deliver notifications, can increase activity levels and reduce salt intake for people with high blood pressure. All study activities will be completed online or via a mobile medical application. Participants will not have any face-to-face visits with the study team.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Self-reported history of hypertension and no hypertensive medication changes in thelast 4 weeks.
  • A smartphone with a compatible Apple or Android operating system installed and able todownload and use the myBPmyLife app including accepting all permissions
  • A valid email address
  • Fluent in spoken and written English
  • Signed written informed consent. (Note that each participant must be able to consentfor themselves.)

Exclusion

Exclusion Criteria:

  • Contraindication to performing physical activity or following a sodium restrictiondiet. The participant must be able to walk and eat on their own without assistivedevices.
  • Unstable symptoms or markedly elevated BP at enrollment (defined as systolic BP>180mmHg, diastolic BP>120 millimeters of mercury (mmHg))
  • Known secondary causes of hypertension (e.g., adrenal insufficiency,pheochromocytoma), heart failure, or end-stage renal disease
  • Difficulty using an upper arm blood pressure cuff due to biceps size or end-stagerenal disease or difficulty comfortably wearing a smartwatch
  • Wrist too large to wear a smartwatch comfortably.
  • Daily sodium intake less than 1500 mg/day as measured by the sodium screener
  • Currently pregnant or planning to become pregnant in the next six months

Study Design

Total Participants: 608
Treatment Group(s): 2
Primary Treatment: Control Group
Phase:
Study Start date:
December 21, 2021
Estimated Completion Date:
January 27, 2024

Connect with a study center

  • University of Michigan

    Ann Arbor, Michigan 48109
    United States

    Site Not Available

  • Hamilton Community Health Network

    Flint, Michigan 48505
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.